Total Hip Arthroplasty in Cirrhosis is Associated with Increased Complications during the Hospital Stay, Length of Stay, and Cost of Care: A Propensity Matched Database Study

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 89

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_TABO-11-5_005

تاریخ نمایه سازی: 27 خرداد 1402

چکیده مقاله:

Objectives: The aim of the study is to evaluate the impact of cirrhosis on inpatient hospital complications and healthcare costs in elective Total Hip Arthroplasty (THA).Methods: A ۴-year retrospective analysis of the Nation Inpatient Sample (NIS) database, who underwent elective THA stratified by the presence or absence of cirrhosis was performed (۲۰۱۶-۱۹). The records of specific postoperative complications, the cost of care (COC), and the length of stay (LOS) were evaluated by statistical analysis. Results: The NIS database identified ۳۶۷,۸۹۴ patients who underwent THA, of which ۱,۱۳۴ (۰.۳%) were cirrhotic. In the unmatched analysis, patients with cirrhosis showed significantly elevated rates (P< ۰.۰۵) of in-hospital complications compared to non-cirrhotic controls, including mortality (۰.۷% vs. ۰.۱%), acute renal failure (۹.۲% vs. ۲.۵%), blood loss anemia (۳۰.۴% vs. ۱۹.۵%), pneumonia (۱.۱% vs. ۰.۳%), periprosthetic fracture (۳% vs. ۱.۲%), dislocations (۲.۵% vs. ۱.۴%), infection (۴.۲% vs. ۱%), wound dehiscence (۰.۸% vs. ۰.۱%) and blood transfusion (۱۱.۳% vs. ۳.۵%). After propensity matching, significantly higher rates of blood loss anemia (۳۰.۴% vs. ۲۶.۷%; P=۰.۰۵), periprosthetic dislocations (۲.۴% vs. ۱%; P=۰.۰۰۸), and infections (۴.۲% vs. ۲.۷%, P=۰.۰۵) were seen in the cirrhotic cohort, while the rate of pulmonary embolism was significantly lower (۰% vs. ۰.۸%, P=۰.۰۰۲), as was myocardial infarction (۰.۰۸% vs. ۰.۷%, P=۰.۰۱۷). Concerning LOS in the hospital, patients with cirrhosis stayed significantly longer in both the unmatched (۴.۲ vs. ۲.۳ days; P <۰.۰۰۱) and matched (۴.۲ vs. ۳.۶۸; P=۰.۰۱۶) controls. The average COC was greater in the cirrhotic group, with a mean value of ۹۰,۲۶۴ vs. ۶۶,۸۰۶.۳۱ (P<۰.۰۰۱) in the unmatched and ۹۰,۶۲۴ vs. ۸۰,۶۷۶.۸۷ (P=۰.۰۰۱) in the matched cohort.Conclusion: Cirrhosis is associated with longer lengths of stay, higher hospital costs, and a greater risk of perioperative in-hospital complications such as blood loss anemia, dislocation, and infection after THA. This data could assist during preoperative patient counseling and improve the strategies for effectively utilizing the finite healthcare resources without compromising patient care and financial compensation from payers.  Level of evidence: IV

نویسندگان

Naga Suresh Cheppalli

Department of Orthopedic and Rehabilitation University of New Mexico, Raymond Murphy Medical Centre, USA

Sreenivasulu Metikala

Virginia Common wealth University, Richmond, VA, USA

Jake Beale

Department of Orthopedics, University of Texas, Southwestern, Dallas, Texas, USA

Varatharaj Mounsamy

Department of Orthopedics, University of Texas, Southwestern, Dallas, Texas, USA

Senthil Sambandam

Department of Orthopedics, University of Texas, Southwestern, Dallas, Texas, USA

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR. Underestimation ...
  • Scaglione S, Kliethermes S, Cao G, et al. The Epidemiology ...
  • Moon AM, Singal AG, Tapper EB. Contemporary Epidemiology of Chronic Liver ...
  • Onochie E, Kayani B, Dawson-Bowling S, Millington S, Achan P, Hanna ...
  • Nicoll A. Surgical risk in patients with cirrhosis. J Gastroenterol Hepatol. ...
  • Berstock JR, Beswick AD, Lenguerrand E, Whitehouse MR, Blom AW. Mortality ...
  • Hunt LP, Ben-Shlomo Y, Clark EM, et al. ۹۰-day mortality ...
  • Cram P, Lu X, Kaboli PJ, et al. Clinical characteristics ...
  • Hillerson D, Ogunbayo GO, Salih M, et al. Outcomes and Characteristics ...
  • An J, Shim JH, Kim SO, et al. Prevalence and ...
  • Westerkamp AC, Lisman T, Porte RJ. How to minimize blood loss ...
  • Liu P, Hum J, Jou J, Scanlan RM, Shatzel J. ...
  • Senzolo M, Sartori MT, Lisman T. Should we give thromboprophylaxis to ...
  • Anand AC. Nutrition and Muscle in Cirrhosis. J Clin Exp Hepatol. ...
  • Jiang SL, Schairer WW, Bozic KJ. Increased rates of periprosthetic joint ...
  • McLawhorn AS, Buller LT. Bundled Payments in Total Joint Replacement: Keeping ...
  • نمایش کامل مراجع